Fig. 4From: Migraine day frequency in migraine prevention: longitudinal modelling approachesMMDs over 12 weeks of the CM study: negative binomial and beta-binomial longitudinal regression estimates and observed data. neg, negative. 95% confidence intervals for the negative and beta-binomials indicated by the shaded grey (placebo) and red (erenumab)Back to article page